Showing results (371-380 of 542) with videos related to

Sort By:
Pageof 55
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 3, 2022
Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)Rachel L O'Connell, Bhupinder Sharma, Liza Van Kerckhoven, et al.
The American Journal of Cardiology|September 28, 2015
Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry)Georg M Fröhlich, Paul D Baxter, Christopher J Malkin, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 20, 2021
DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Cancers|May 30, 2019
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric AdenocarcinomaMichael Davidson, Louise J Barber, Andrew Woolston, et al.
Autism Research : Official Journal of the International Society for Autism Research|February 11, 2011
Contactin 4 as an autism susceptibility locusCatherine E Cottrell, Natalie Bir, Elizabeth Varga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.
The Journal of Biological Chemistry|January 12, 2010
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1Michelle Pacholec, John E Bleasdale, Boris Chrunyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialArnaud D Roth, Sabine Tejpar, Mauro Delorenzi, et al.
Journal of Surgical Oncology|August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinomaMohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.
Pageof 55